Catalyst Wire Dossier Catalyst Wire Dossier

Minzasolmin

UCB0599 · UCB Biopharma SRL
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Minzasolmin, covering 2025-11-26 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease [Phase 2]

See pricing